Does hereditary spherocytosis raise total bilirubin even with normal ALT and alkaline phosphatase?

Hereditary spherocytosis (HS) is a genetic hematologic disorder characterized by defects in red blood cell (RBC) membrane proteins, such as ankyrin, spectrin, or band 3. These defects lead to a loss of cell surface area, resulting in rigid, spherical cells that are poorly deformable and prone to entrapment and destruction within the spleen.

Mechanistic evidence

The pathophysiology of hyperbilirubinemia in HS is rooted in the chronic extravascular hemolysis of these defective RBCs.

• Splenic Entrapment: Rigid spherocytes become mechanically trapped in the splenic cords. Splenic macrophages recognize and sequester these cells, initiating their destruction within the red pulp.
• Heme Degradation Pathway: Inside the macrophages, hemoglobin is released and broken down. The heme portion is converted by the enzyme heme oxygenase-1 (HO-1) into biliverdin, which is then rapidly reduced by biliverdin reductase (BVR) to unconjugated (indirect) bilirubin.
• Increased Bilirubin Load: The accelerated rate of RBC destruction in HS causes a significant spike in the daily production of unconjugated bilirubin, often exceeding the liver’s baseline capacity for hepatic conjugation.
• Genetic Modifiers: Many patients with HS and disproportionately high bilirubin levels (hyperjaundice) carry coexisting variants in the UGT1A1 gene (Gilbert syndrome). This combination impairs the liver's ability to conjugate the high volume of bilirubin produced by hemolysis, further elevating serum levels.

Clinical evidence

Hereditary spherocytosis typically presents with a biochemical profile characteristic of pre-hepatic jaundice.

• Isolated Hyperbilirubinemia: Total bilirubin is frequently elevated, with the unconjugated fraction typically accounting for more than 85% of the total.
• Liver Enzyme Stability: Because the source of bilirubin is the destruction of RBCs (a hematologic process) rather than liver cell injury or bile duct obstruction, markers of hepatocellular integrity (ALT) and cholestasis (Alkaline Phosphatase) remain within normal reference ranges.
• Complications: Chronic elevation of unconjugated bilirubin is a primary driver for the formation of calcium bilirubinate (pigment) gallstones, which occur in approximately 20–50% of HS patients.
• Treatment Response: Removal of the primary site of RBC destruction via splenectomy leads to a rapid and sustained decrease in total bilirubin levels, even though the underlying RBC membrane defect persists.

Bottom line

Hereditary spherocytosis causes a specific pattern of isolated unconjugated hyperbilirubinemia due to the accelerated destruction of rigid red cells in the spleen. This increase in total bilirubin occurs independently of liver function, meaning that alanine aminotransferase (ALT) and alkaline phosphatase (ALP) typically remain normal unless secondary complications like pigment gallstones cause biliary obstruction.